Literature DB >> 16718772

Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation.

Hong Ren1, Ning Du, Gang Liu, Heng-Tong Hu, Wei Tian, Zhi-Ping Deng, Jing-Sen Shi.   

Abstract

AIM: To study the variabilities of serum proteomic spectra in patients with gastric cancer before and after operation in order to detect the specific protein markers that can be used for quick diagnosis of gastric cancer.
METHODS: Proteomic spectra of 46 serum samples from patients with gastric cancer before and after operation and 40 from normal individuals were generated by IMAC-Cu protein chip and surface-enhanced laser desorption/ ionization time of flight mass spectrometry.
RESULTS: Fourteen differentially expressed proteins in serum were screened by analysis of proteomic spectra of preoperative patients and normal individuals. We obtained 4 proteins (heat shock protein 27, glucose-regulated protein, prohibitin, protein disulfide isomerase A3) making up marker pattern which was able to class the patient-team and normal-team. These marker patterns yielded 95.7% sensitivity and 92.5% specificity, respectively. The proteins over-expressed in serum of preoperative patients were obviously down-regulated.
CONCLUSION: Specific protein markers of gastric cancer can be used for the quick diagnosis of gastric cancer and judgment of prognosis. SELDI-TOF-MS is a useful tool for the detection and identification of new protein markers in serum.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718772      PMCID: PMC4130994          DOI: 10.3748/wjg.v12.i17.2789

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  14 in total

Review 1.  Trends in biomarker research for cancer detection.

Authors:  P R Srinivas; B S Kramer; S Srivastava
Journal:  Lancet Oncol       Date:  2001-11       Impact factor: 41.316

2.  Heat-resistant variants of Chinese hamster fibroblasts altered in expression of heat shock protein.

Authors:  A Laszlo; G C Li
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

Review 3.  Multidrug resistance.

Authors:  J A Moscow; K H Cowan
Journal:  J Natl Cancer Inst       Date:  1988-03-02       Impact factor: 13.506

Review 4.  Molecular mechanisms of multidrug resistance in cancer chemotherapy.

Authors:  K Nooter; G Stoter
Journal:  Pathol Res Pract       Date:  1996-07       Impact factor: 3.250

5.  Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine.

Authors:  A Vlahou; P F Schellhammer; S Mendrinos; K Patel; F I Kondylis; L Gong; S Nasim; G L Wright
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 6.  Cancer proteomics: from biomarker discovery to signal pathway profiling.

Authors:  V E Bichsel; L A Liotta; E F Petricoin
Journal:  Cancer J       Date:  2001 Jan-Feb       Impact factor: 3.360

7.  Mass spectrometry meets chip technology: a new proteomic tool in cancer research?

Authors:  F von Eggeling; K Junker; W Fiedle; V Wollscheid; M Dürst; U Claussen; G Ernst
Journal:  Electrophoresis       Date:  2001-08       Impact factor: 3.535

8.  Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research.

Authors:  F von Eggeling; H Davies; L Lomas; W Fiedler; K Junker; U Claussen; G Ernst
Journal:  Biotechniques       Date:  2000-11       Impact factor: 1.993

9.  Seroprevalence of Helicobacter pylori infection in medical staff in Shanghai.

Authors:  W Z Liu; S D Xiao; S J Jiang; R R Li; Z J Pang
Journal:  Scand J Gastroenterol       Date:  1996-08       Impact factor: 2.423

10.  Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer.

Authors:  C P Paweletz; B Trock; M Pennanen; T Tsangaris; C Magnant; L A Liotta; E F Petricoin
Journal:  Dis Markers       Date:  2001       Impact factor: 3.434

View more
  11 in total

1.  Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women.

Authors:  Jon J Ladd; Tina Busald; Melissa M Johnson; Qing Zhang; Sharon J Pitteri; Hong Wang; Dean E Brenner; Paul D Lampe; Raju Kucherlapati; Ziding Feng; Ross L Prentice; Samir M Hanash
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-25

2.  Serum peptidome profiling in patients with gastric cancer.

Authors:  Juan Yang; Yong-Chun Song; Cheng-Xue Dang; Tu-Sheng Song; Zhi-Gang Liu; You-Min Guo; Zong-Fang Li; Chen Huang
Journal:  Clin Exp Med       Date:  2011-07-08       Impact factor: 3.984

3.  Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma.

Authors:  Yashwanth Subbannayya; Nazia Syed; Mustafa A Barbhuiya; Remya Raja; Arivusudar Marimuthu; Nandini Sahasrabuddhe; Sneha M Pinto; Srikanth Srinivas Manda; Santosh Renuse; H C Manju; Mohammed Abdul Lateef Zameer; Jyoti Sharma; Mariana Brait; Kotteazeth Srikumar; Juan Carlos Roa; M Vijaya Kumar; K V Veerendra Kumar; T S Keshava Prasad; Girija Ramaswamy; Rekha Vijay Kumar; Akhilesh Pandey; Harsha Gowda; Aditi Chatterjee
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

4.  Prohibitin: a potential biomarker for tissue-based detection of gastric cancer.

Authors:  Xiangdong Kang; Long Zhang; Jian Sun; Zhenhua Ni; Yanchun Ma; Xiaobo Chen; Xia Sheng; Teng Chen
Journal:  J Gastroenterol       Date:  2008-08-17       Impact factor: 7.527

Review 5.  Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers.

Authors:  Ken Herrmann; Axel Walch; Benjamin Balluff; Marc Tänzer; Heinz Höfler; Bernd J Krause; Markus Schwaiger; Helmut Friess; Roland M Schmid; Matthias P A Ebert
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2009-03

6.  Serum biomarker panels for the diagnosis of gastric adenocarcinoma.

Authors:  H S Ahn; Y S Shin; P J Park; K N Kang; Y Kim; H-J Lee; H-K Yang; C W Kim
Journal:  Br J Cancer       Date:  2012-01-12       Impact factor: 7.640

7.  Identification of differentially expressed serum proteins in gastric adenocarcinoma.

Authors:  Yashwanth Subbannayya; Sartaj Ahmad Mir; Santosh Renuse; Srikanth S Manda; Sneha M Pinto; Vinuth N Puttamallesh; Hitendra Singh Solanki; H C Manju; Nazia Syed; Rakesh Sharma; Rita Christopher; M Vijayakumar; K V Veerendra Kumar; T S Keshava Prasad; Girija Ramaswamy; Rekha V Kumar; Aditi Chatterjee; Akhilesh Pandey; Harsha Gowda
Journal:  J Proteomics       Date:  2015-05-05       Impact factor: 4.044

Review 8.  The current state of proteomics in GI oncology.

Authors:  Ying Lin; William S Dynan; Jeffrey R Lee; Zhao-Hua Zhu; Robert R Schade
Journal:  Dig Dis Sci       Date:  2008-12-23       Impact factor: 3.199

9.  Prohibitin expression deregulation in gastric cancer is associated with the 3' untranslated region 1630 C>T polymorphism and copy number variation.

Authors:  Mariana Ferreira Leal; Priscila Daniele Ramos Cirilo; Tatiane Katsue Furuya Mazzotti; Danielle Queiroz Calcagno; Fernanda Wisnieski; Samia Demachki; Margarita Cortes Martinez; Paulo Pimentel Assumpção; Roger Chammas; Rommel Rodríguez Burbano; Marília Cardoso Smith
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

10.  MMP9 processing of HSPB1 regulates tumor progression.

Authors:  Seo-hyun Choi; Hae-June Lee; Yeung Bae Jin; Junho Jang; Ga-young Kang; Minyoung Lee; Chun-Ho Kim; Joon Kim; Sam S Yoon; Yun-sil Lee; Yoon-Jin Lee
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.